These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4472253)

  • 1. Proceedings: Effect of salmon calcitonin treatment on bone turnover, cardiac output and oxygen transport in patients with Paget's disease.
    Crosbie WA; Woodhouse NJ
    Clin Sci Mol Med; 1974 Aug; 47(2):5P-6P. PubMed ID: 4472253
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of salmon calcitonin on cardiac output, oxygen transport and bone turnover in patients with Paget's disease.
    Crosbie WA; Mohamedally SM; Woodhouse NJ
    Clin Sci Mol Med Suppl; 1975 Jun; 48(6):537-40. PubMed ID: 1056285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac output in Paget's disease: response to long-term salmon calcitonin therapy.
    Woodhouse NJ; Crosbie WA; Mohamedally SM
    Br Med J; 1975 Dec; 4(5998):686. PubMed ID: 1203724
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of prolonged thyrocalcitonin administration on Paget's disease of bone.
    Haddad JG; Birge SJ; Avioli LV
    N Engl J Med; 1970 Sep; 283(11):549-55. PubMed ID: 5450609
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term treatment of Paget's disease of bone with salmon calcitonin.
    Sturtridge WC; Harrison JE; Wilson DR
    Can Med Assoc J; 1977 Nov; 117(9):1031-4. PubMed ID: 562231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cardiovascular system in Paget's disease of bone and the response to therapy with calcitonin and diphosphonate.
    Henley JW; Croxson RS; Ibbertson HK
    Aust N Z J Med; 1979 Aug; 9(4):390-7. PubMed ID: 292378
    [No Abstract]   [Full Text] [Related]  

  • 7. Remissions in Paget's disease produced by human synthetic calcitonin (calcitonin M).
    Woodhouse NJ; Reiner M; Kalu DN; Galante L; Joplin GF; MacIntyre I
    Clin Sci; 1970 Sep; 39(3):9P-10P. PubMed ID: 5459177
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of the combined calcitonin and sodium etidronate therapy in Paget's disease of bone].
    Nuti R; Turchetti V; Righi G; Vattimo A
    Minerva Med; 1982 Mar; 73(9):467-72. PubMed ID: 6801555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New method of measuring total and regional bone fixation of calcium in patients with Paget's disease treated with salmon calcitonin].
    Bergmann P; Schoutens A; Corvilain J
    Strahlentherapie Sonderb; 1975; 74():301-8. PubMed ID: 1239103
    [No Abstract]   [Full Text] [Related]  

  • 10. Bone turnover in Paget's disease: biochemical and kinetic measurements during salmon calcitonin therapy.
    Hosking DJ; Vennart W; Huddlestone LB
    Calcif Tissue Int; 1981; 33(5):471-6. PubMed ID: 6797699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Paget's disease with calcitonin.
    DeRose J; Avramides A; Baker RK; Wallach S
    Semin Drug Treat; 1972; 2(1):51-5. PubMed ID: 5065517
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolic balance studies in patients with Paget's disease receiving salmon calcitonin over long periods.
    Oreopoulos DG; Husdan H; Harrison J; Meema HE; McNeill KG; Murray TM; Ogilvie R; Rapoport A
    Can Med Assoc J; 1977 Apr; 116(8):851-5. PubMed ID: 856428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The treatment of Paget's disease using salmon thyrocalcitonin. 8 cases (author's transl)].
    Deplante JP; Daumont A; Bouvier M; Lejeune E
    Nouv Presse Med; 1978 Nov; 7(41):3753-6. PubMed ID: 733525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paget's disease. Radiological changes occurring in untreated patients and those on therapy with salmon calcitonin during two years' observation.
    Woodhouse NJ; Chalmers AH; Wells IP; Dewbury KC; Mohamedally SM
    Br J Radiol; 1977 Oct; 50(598):699-705. PubMed ID: 562693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Paget's disease of bone with salmon calcitonin.
    Manderlier T; Fuss M; Brauman J; Orloff S; Bergans A; Corvilain J
    Acta Clin Belg; 1976; 31(6):329-38. PubMed ID: 1035459
    [No Abstract]   [Full Text] [Related]  

  • 16. Functional significance of antibody formation after long-term salmon calcitonin therapy.
    Hosking DJ; Denton LB; Cadge B; Martin TJ
    Clin Endocrinol (Oxf); 1979 Mar; 10(3):243-52. PubMed ID: 572275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paget's bone disease: response to human calcitonin in patients resistant to salmon calcitonin.
    Rojanasathit S; Rosenberg E; Haddad JG
    Lancet; 1974 Dec; 2(7894):1412-5. PubMed ID: 4140329
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic effects of synthetic salmon calcitonin in Paget's disease of bone.
    Avramides A; Baker RK; Wallach S
    Metabolism; 1974 Nov; 23(11):1037-46. PubMed ID: 4472557
    [No Abstract]   [Full Text] [Related]  

  • 19. Human calcitonin treatment of Paget's disease of bone.
    Singer FR
    Clin Orthop Relat Res; 1977; (127):86-93. PubMed ID: 912995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salmon and porcine calcitonin treatment of Paget's disease of bone.
    Avramides A
    Clin Orthop Relat Res; 1977; (127):78-85. PubMed ID: 303164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.